Consistent with their previously described roles in glioma cells, we performed the immunohistochemistry assay to examine NAP1L1 and HDGF expressions in 108 gliomas tissues compared to those in 24 para-tumor tissues. Here, NAP1L1 is linked to central nervous system cancer.